Your session is about to expire
← Back to Search
Sign Here: How to Conduct Informed Consent With Deaf Individuals
N/A
Waitlist Available
Led By Melissa L Anderson
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, up to one month
Awards & highlights
No Placebo-Only Group
Summary
This trial will create a training film to help healthcare providers interact better with Deaf patients. Focus groups and a research trial will be conducted to make it happen.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention, up to one month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, up to one month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Ask, Understand, Remember Assessment
Healthcare Provider Cultural Competency
Wake Forest Physician Trust Scale
Secondary study objectives
Assessment of Intervention Understanding & Retention
Self-Rating of Simulation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention as usualExperimental Treatment1 Intervention
Participants randomized to intervention as usual will review "Communicating with People Who Are Deaf or Hard of Hearing in Hospital Settings" (https://archive.ada.gov/hospcombrprt.pdf)
Group II: "Sign Here" training interventionExperimental Treatment1 Intervention
Participants randomized to the experimental condition will view the new "Sign Here" training film for healthcare providers.
Find a Location
Who is running the clinical trial?
University of Massachusetts, WorcesterLead Sponsor
362 Previous Clinical Trials
992,512 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,850 Total Patients Enrolled
Brown UniversityOTHER
466 Previous Clinical Trials
699,272 Total Patients Enrolled
Melissa L AndersonPrincipal Investigatormelissa.anderson@umassmed.edu
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Intervention as usual
- Group 2: "Sign Here" training intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.